| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
RAPID COMMUNICATIONS |
í H
ebí
ek,
Vladimír Janout,
Jana Malin
íková,
Dagmar Horáková and
Lud
k
í
ek
Department of Physiology, Department of Preventive Medicine,
Department of Exercise Medicine, Faculty of Medicine, Palack
University, Olomouc, Czech Republic 77515, Europe
The aim of the present study was to evaluate the recently defined simple insulin sensitivity check index QUICKI (Katz et al. 2000) for insulin resistance diagnostics in common clinical and epidemiological practice. Both the QUICKI (1/log insulin + log glycemia in mg/dL) and HOMA (insulin * glycemia in µmol/L/22.5) indexes were calculated from fasting values in 259 adult healthy volunteers and patients, and in 47 healthy and obese children of prepubertal age of both sexes. In adults, a fall in the QUICKI index (mean ± SEM in healthy subjects = 0.366 ± 0.029) as well as an increase in the HOMA index (in healthy subjects 1.57 ± 0.87) corresponded to metabolic and clinical manifestations of insulin resistance in various groups of outpatients. The QUICKI index had lower dispersion variances and the 95% confidence limits displayed a higher discrimination capacity. Patients with glucose intolerance or diabetes, hyperlipidemia typical for insulin resistance, or with combination of these metabolic disorders were characterized by QUICKI index values that were significantly lower than those of healthy volunteers. The QUICKI index in healthy prepubertal children indicated a higher insulin resistance compared to adults (mean 0.339 ± 0.020); an increase in the QUICKI index in obese children with BMI over 25 was not significant, although obese children showed a significant increase of serum leptin and triglycerides and a decrease of HDL-cholesterol. Adult patients with QUICKI index below 0.357 (which is at the lower limit of 95% confidence limits in healthy persons) represented a group with typical manifestations of metabolic syndrome, differing in these parameters significantly from the group of patients of comparable age with a QUICKI index greater than 0.357. The present study suggests suitability of the QUICKI index for diagnosis of insulin resistance in clinical and epidemiological practice. However, a normal QUICKI index range needs to be established for each laboratory with an appropriate control group because of significant interlaboratory variations in insulin determinations and/or possible differences in various populations.
This article has been cited by other articles:
![]() |
H. K. White, C. D. Petrie, W. Landschulz, D. MacLean, A. Taylor, K. Lyles, J. Y. Wei, A. R. Hoffman, R. Salvatori, M. P. Ettinger, et al. Effects of an Oral Growth Hormone Secretagogue in Older Adults J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1198 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
S A Harrison, D Oliver, H L Arnold, S Gogia, and B A Neuschwander-Tetri Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease Gut, October 1, 2008; 57(10): 1441 - 1447. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Gomez-Valades, A. Mendez-Lucas, A. Vidal-Alabro, F. X. Blasco, M. Chillon, R. Bartrons, J. Bermudez, and J. C. Perales Pck1 Gene Silencing in the Liver Improves Glycemia Control, Insulin Sensitivity, and Dyslipidemia in db/db Mice Diabetes, August 1, 2008; 57(8): 2199 - 2210. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Misra, M. A. Bredella, P. Tsai, N. Mendes, K. K. Miller, and A. Klibanski Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E385 - E392. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Damsgaard, H. Frokiaer, A. D. Andersen, and L. Lauritzen Fish Oil in Combination with High or Low Intakes of Linoleic Acid Lowers Plasma Triacylglycerols but Does Not Affect Other Cardiovascular Risk Markers in Healthy Men J. Nutr., June 1, 2008; 138(6): 1061 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Emmelot-Vonk, H. J. J. Verhaar, H. R. Nakhai Pour, A. Aleman, T. M. T. W. Lock, J. L. H. R. Bosch, D. E. Grobbee, and Y. T. van der Schouw Effect of Testosterone Supplementation on Functional Mobility, Cognition, and Other Parameters in Older Men: A Randomized Controlled Trial JAMA, January 2, 2008; 299(1): 39 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kajaia, H. Binder, R. Dittrich, P. G Oppelt, B. Flor, S. Cupisti, M. W Beckmann, and A. Mueller Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome Eur. J. Endocrinol., October 1, 2007; 157(4): 499 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gilliam-Davis, V. S. Payne, S. O. Kasper, E. N. Tommasi, M. E. Robbins, and D. I. Diz Long-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1327 - H1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Beltrand, M. Beregszaszi, D. Chevenne, G. Sebag, M. De Kerdanet, F. Huet, M. Polak, N. Tubiana-Rufi, D. Lacombe, A. M. De Paoli, et al. Metabolic Correction Induced by Leptin Replacement Treatment in Young Children With Berardinelli-Seip Congenital Lipoatrophy Pediatrics, August 1, 2007; 120(2): e291 - e296. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. M. Rajala, S. M. Keinanen-Kiukaanniemi, P. K. Hirsso, J. J. Jokelainen, M. A. Laakso, L. A. Hiltunen, A. O. Ruokonen, P. K. Harkonen, and M. J. Timonen Associations of Total Testosterone and Sex Hormone-Binding Globulin Levels With Insulin Sensitivity in Middle-Aged Finnish Men Diabetes Care, April 1, 2007; 30(4): e13 - e13. [Full Text] [PDF] |
||||
![]() |
J. Bronsky, M. Karpisek, E. Bronska, M. Pechova, B. Jancikova, H. Kotolova, D. Stejskal, R. Prusa, and J. Nevoral Adiponectin, Adipocyte Fatty Acid Binding Protein, and Epidermal Fatty Acid Binding Protein: Proteins Newly Identified in Human Breast Milk Clin. Chem., September 1, 2006; 52(9): 1763 - 1770. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Gannage-Yared, S. Khalife, M. Semaan, F. Fares, S. Jambart, and G. Halaby Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur. J. Endocrinol., July 1, 2006; 155(1): 167 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salerno, V. Esposito, V. Farina, G. Radetti, A. Umbaldo, D. Capalbo, L. Spinelli, S. Muzzica, G. Lombardi, and A. Colao Improvement of Cardiac Performance and Cardiovascular Risk Factors in Children with GH Deficiency after Two Years of GH Replacement Therapy: An Observational, Open, Prospective, Case-Control Study J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1288 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muller, D. E. Grobbee, I. den Tonkelaar, S. W. J. Lamberts, and Y. T. van der Schouw Endogenous Sex Hormones and Metabolic Syndrome in Aging Men J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2618 - 2623. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, R. P. Wildman, L. L. Hamm, P. Muntner, K. Reynolds, P. K. Whelton, and J. He Association Between Inflammation and Insulin Resistance in U.S. Nondiabetic Adults: Results from the Third National Health and Nutrition Examination Survey Diabetes Care, December 1, 2004; 27(12): 2960 - 2965. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reinehr, W. Kiess, T. Kapellen, and W. Andler Insulin Sensitivity Among Obese Children and Adolescents, According to Degree of Weight Loss Pediatrics, December 1, 2004; 114(6): 1569 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Diamanti-Kandarakis, C. Kouli, K. Alexandraki, and G. Spina Failure of Mathematical Indices to Accurately Assess Insulin Resistance in Lean, Overweight, or Obese Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1273 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yokoyama, M. Emoto, S. Fujiwara, K. Motoyama, T. Morioka, M. Komatsu, H. Tahara, H. Koyama, T. Shoji, M. Inaba, et al. Quantitative Insulin Sensitivity Check Index and the Reciprocal Index of Homeostasis Model Assessment Are Useful Indexes of Insulin Resistance in Type 2 Diabetic Patients with Wide Range of Fasting Plasma Glucose J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1481 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Ascaso, S. Pardo, J. T. Real, R. I. Lorente, A. Priego, and R. Carmena Diagnosing Insulin Resistance by Simple Quantitative Methods in Subjects With Normal Glucose Metabolism Diabetes Care, December 1, 2003; 26(12): 3320 - 3325. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rabasa-Lhoret, J.-P. Bastard, V. Jan, P.-H. Ducluzeau, F. Andreelli, F. Guebre, J. Bruzeau, C. Louche-Pellissier, C. MaItrepierre, J. Peyrat, et al. Modified Quantitative Insulin Sensitivity Check Index Is Better Correlated to Hyperinsulinemic Glucose Clamp than Other Fasting-Based Index of Insulin Sensitivity in Different Insulin-Resistant States J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4917 - 4923. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, G. Sullivan, L. Q. Yue, A. Katz, and M. J. Quon QUICKI is a useful index of insulin sensitivity in subjects with hypertension Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E804 - E812. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Kolovou, D. Ch. Daskalova, S. A. Iraklianou, E. N. Adamopoulou, N. D. Pilatis, G. C. Hatzigeorgiou, and D. V. Cokkinos Postprandial Lipemia in Hypertension J. Am. Coll. Nutr., February 1, 2003; 22(1): 80 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. I. Uwaifo, E. M. Fallon, J. Chin, J. Elberg, S. J. Parikh, and J. A. Yanovski Indices of Insulin Action, Disposal, and Secretion Derived From Fasting Samples and Clamps in Normal Glucose-Tolerant Black and White Children Diabetes Care, November 1, 2002; 25(11): 2081 - 2087. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Katsuki, Y. Sumida, E. C. Gabazza, S. Murashima, H. Urakawa, K. Morioka, N. Kitagawa, T. Tanaka, R. Araki-Sasaki, Y. Hori, et al. QUICKI Is Useful for Following Improvements in Insulin Sensitivity after Therapy in Patients with Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2906 - 2908. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |